Staar Surgical adjourns vote on acquisition by Alcon
Published by Global Banking & Finance Review®
Posted on October 23, 2025
1 min readLast updated: January 21, 2026
Published by Global Banking & Finance Review®
Posted on October 23, 2025
1 min readLast updated: January 21, 2026
Staar Surgical has delayed its shareholder vote on Alcon's $1.5 billion acquisition offer to November 6 due to investor opposition.
(Reuters) -Staar Surgical has adjourned its shareholder vote on Swiss eyecare giant Alcon's $1.5 billion takeover offer until November 6, the company said on Thursday.
The delay comes amid opposing campaigns between Staar's board and key investors, led by Broadwood Partners which owns 27.5%. Opposing shareholders argue that the deal undervalues the business and reflects a flawed sale process.
(Reporting by Maria Rugamer; Editing by Matt Scuffham)
An acquisition is a corporate action in which one company purchases most or all of another company's shares to gain control of that company.
Corporate governance refers to the systems, principles, and processes by which a company is directed and controlled, ensuring accountability and transparency in its operations.
Valuations are assessments of the worth or value of a company, asset, or investment, often used in mergers and acquisitions to determine fair pricing.
A takeover offer is a proposal made by one company to purchase another company, usually at a specified price per share, often to gain control over the target company.
Explore more articles in the Finance category

